Neuron23 Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Neuron23's estimated annual revenue is currently $5.3M per year.(i)
  • Neuron23's estimated revenue per employee is $77,500

Employee Data

  • Neuron23 has 68 Employees.(i)
  • Neuron23 grew their employee count by 33% last year.

Neuron23's People

NameTitleEmail/Phone
1
Founder and CBOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Business OfficerReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
Head Regulatory AffairsReveal Email/Phone
6
VP Clinical OperationsReveal Email/Phone
7
VP Finance & Corporate ControllerReveal Email/Phone
8
SVP Research OperationsReveal Email/Phone
9
SVP Chemistry & DMPKReveal Email/Phone
10
EVP Drug DiscoveryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Neuron23?

Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 leverages recent advances in human genetics, combined with their state-of-the-art artificial intelligence (AI)-enabled drug discovery and biomarker platforms, to advance therapeutics for devastating diseases. The Company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA, and Munich, Germany.

keywords:N/A

N/A

Total Funding

68

Number of Employees

$5.3M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.3M68-1%$101.6M
#2
$15.3M68-9%N/A
#3
$8.6M68-35%$46.5M
#4
$6.2M6828%N/A
#5
$8.3M688%N/A